全文获取类型
收费全文 | 7551篇 |
免费 | 417篇 |
国内免费 | 93篇 |
专业分类
耳鼻咽喉 | 101篇 |
儿科学 | 108篇 |
妇产科学 | 110篇 |
基础医学 | 796篇 |
口腔科学 | 242篇 |
临床医学 | 668篇 |
内科学 | 2211篇 |
皮肤病学 | 76篇 |
神经病学 | 869篇 |
特种医学 | 495篇 |
外科学 | 1079篇 |
综合类 | 9篇 |
预防医学 | 250篇 |
眼科学 | 74篇 |
药学 | 415篇 |
中国医学 | 10篇 |
肿瘤学 | 548篇 |
出版年
2024年 | 13篇 |
2023年 | 112篇 |
2022年 | 206篇 |
2021年 | 337篇 |
2020年 | 240篇 |
2019年 | 261篇 |
2018年 | 285篇 |
2017年 | 186篇 |
2016年 | 266篇 |
2015年 | 270篇 |
2014年 | 315篇 |
2013年 | 422篇 |
2012年 | 609篇 |
2011年 | 594篇 |
2010年 | 322篇 |
2009年 | 270篇 |
2008年 | 369篇 |
2007年 | 422篇 |
2006年 | 368篇 |
2005年 | 349篇 |
2004年 | 344篇 |
2003年 | 277篇 |
2002年 | 235篇 |
2001年 | 104篇 |
2000年 | 82篇 |
1999年 | 76篇 |
1998年 | 59篇 |
1997年 | 43篇 |
1996年 | 37篇 |
1995年 | 31篇 |
1994年 | 24篇 |
1993年 | 35篇 |
1992年 | 54篇 |
1991年 | 52篇 |
1990年 | 53篇 |
1989年 | 51篇 |
1988年 | 41篇 |
1987年 | 27篇 |
1986年 | 27篇 |
1985年 | 21篇 |
1984年 | 25篇 |
1983年 | 16篇 |
1982年 | 8篇 |
1979年 | 10篇 |
1978年 | 9篇 |
1974年 | 10篇 |
1973年 | 10篇 |
1971年 | 8篇 |
1968年 | 7篇 |
1966年 | 7篇 |
排序方式: 共有8061条查询结果,搜索用时 31 毫秒
71.
Luca Degli Esposti Valentina Perrone Diego Sangiorgi Margherita Andretta Fausto Bartolini Arturo Cavaliere Andrea Ciaccia Stefania Dell'orco Stefano Grego Sara Salzano Loredana Ubertazzo Adriano Vercellone Davide Gatti Angelo Fassio Ombretta Viapiana Maurizio Rossini Giovanni Adami 《Journal of bone and mineral research》2021,36(11):2177-2183
The determinants of the susceptibility to severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection and severe coronavirus disease 2019 (COVID-19) manifestations are yet not fully understood. Amino-bisphosphonates (N-BPs) have anti-inflammatory properties and have been shown to reduce the incidence of lower respiratory infections, cardiovascular events, and cancer. We conducted a population-based retrospective observational cohort study with the primary objective of determining if oral N-BPs treatment can play a role in the susceptibility to development of severe COVID-19. Administrative International Classification of Diseases, Ninth Revision, Clinical ModificationI (ICD-9-CM) and anatomical-therapeutic chemical (ATC) code data, representative of Italian population (9% sample of the overall population), were analyzed. Oral N-BPs (mainly alendronate and risedronate) were included in the analysis, zoledronic acid was excluded because of the low number of patients at risk. Incidence of COVID-19 hospitalization was 12.32 (95% confidence interval [CI], 9.61–15.04) and 11.55 (95% CI, 8.91–14.20), of intensive care unit (ICU) utilization because of COVID-19 was 1.25 (95% CI, 0.38–2.11) and 1.42 (95% CI, 0.49–2.36), and of all-cause death was 4.06 (95% CI, 2.50–5.61) and 3.96 (95% CI, 2.41–5.51) for oral N-BPs users and nonusers, respectively. Sensitivity analyses that excluded patients with prevalent vertebral or hip fragility fractures and without concomitant glucocorticoid treatment yielded similar results. In conclusion, we found that the incidence of COVID-19 hospitalization, intensive care unit (ICU) utilization, and COVID-19 potentially related mortality were similar in N-BPs–treated and nontreated subjects. Similar results were found in N-BPs versus other anti-osteoporotic drugs. We provide real-life data on the safety of oral N-BPs in terms of severe COVID-19 risk on a population-based cohort. Our results do not support the hypothesis that oral N-BPs can prevent COVID-19 infection and/or severe COVID-19; however, they do not seem to increase the risk. © 2021 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). 相似文献
72.
Antonio Loforte Mariafrancesca Fiorentino Giacomo Murana Gregorio Gliozzi Giulio Giovanni Cavalli Carlo Mariani Sofia Martin Suarez Davide Pacini 《Transplantation proceedings》2021,53(1):311-317
BackgroundThe occurrence of early graft failure (EGF) after heart transplantation (Htx) often requires a mechanical circulatory support (MCS) therapy. The aims of our study were to identify risk factors of mechanically supported severe EGF and evaluate their impact on both early and late outcomes.MethodsBetween January 2000 and December 2019, 499 consecutive adult patients underwent Htx at our institution. Severe EGF was defined as the need for extracorporeal life support (ECLS) within 24 hours after surgery. All available recipient and donor variables were retrospectively analyzed.ResultsOverall, EGF occurred in 58 (11.6%) patients. Post-Htx peripheral or central ECLS was necessary in 32 (6.4%) cases. Independent predictors of severe EGF were, in the recipient group, preoperative transpulmonary gradient (TPG) >12 mm Hg (odds ratio [OR] 4.1, P = .013), preoperative inotropic score >10 (OR 7.3, P = .0001), and pre-Htx ECLS support (OR 5.2, P = .015), while in the donors, a Eurotransplant donor score ≥17 (OR 8.5, P = .005). The absence of EGF was related with a better survival at 1 year and 5 years (94% and 85%, respectively) compared with EGF requiring ECLS population (36% and 28% at 1 year and 5 years, respectively; P < .001). A five-year conditional survival rate did not differ significantly (85% no EGF vs 83% EGF requiring ECLS).ConclusionBoth donor and recipient factors may influence EGF occurrence. Post-Htx ECLS may impact negatively early; however, patients weaned from ECLS eventually benefit from such a rescue treatment with outcomes comparable with Htx patients who did not suffer EGF. 相似文献
73.
Fausto Biancari Giovanni Mariscalco Magnus Dalén Nicla Settembre Henryk Welp Andrea Perrotti Karsten Wiebe Enrico Leo Antonio Loforte Sidney Chocron Davide Pacini Tatu Juvonen L. Mikael Broman Dario Di Perna Hakeem Yusuff Chris Harvey Nicolas Mongardon Juan P. Maureira Antonio Fiore 《Journal of cardiothoracic and vascular anesthesia》2021,35(7):1999-2006
74.
75.
76.
77.
Ohne Zusammenfassung 相似文献
78.
The authors report a case of primary plasma cell leukemia and two cases of multiple myeloma with a large number of circulating plasma cells. The display of Technicon H-1 shows a very high "cloud" in the area of large unstained cells. A massive invasion of the basophil area was not found. Differences between these results and those found in different lymphoid leukemias are discussed. 相似文献
79.
Gialdroni Grassi G 《International journal of antimicrobial agents》1993,3(Z1):S31-S46
The main features and the present position of tetracyclines are reviewed. The mechanism of their action, bacterial resistance and the most recent findings are reported. Their decreased use is due to the availability of new, active, better-tolerated antibiotics. However, tetracyclines still have a place in the treatment of chlamydial and rickettsial infections, brucellosis and Lyme disease. In respiratory infections, they can be employed when necessary in infections caused by Chlamydia psittaci, C. pneumoniae, Mycoplasma pneumoniae, and also by Streptococcus pneumoniae and Haemophilus influenzae, whose rates of resistance now seem lower than in the past when tetracyclines were more largely prescribed. 相似文献
80.
Experimental animal studies carried out over the past 40 years have unequivocally shown that neurogenic mechanisms are involved in the pathogenesis of hypertension. The results of these studies also suggest that neural factors are important not only in the development but also in the maintenance of the high blood pressure condition. Whether this is the case also for human hypertension has been matter of debate for several decades. However, recent studies in man by employing sophisticated techniques for assessing sympathetic tone, i.e. the norepinephrine radiolabelled technique and microneurographic recording of sympathetic nerve traffic, support the hypothesis that alterations in sympathetic modulation of the cardiovascular system take place in hypertension and may have a pathogenetic relevance in age-related blood pressure increase. 相似文献